KROS - Keros Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - KROS (1664710)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
10 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2023-11-04
KROSRegnante KeithCFOS - Sale+OE$45.29-40,0000-100%-$1,811,600
DM
2023-06-08
KROSRegnante KeithCFOS - Sale+OE$46.61-40,0000-100%-$1,864,239
2020-04-13
KROSKnowles JuliusDirP - Purchase$20.98+1,191575,4920%+$24,987
D
2022-07-15
KROSLachey JenniferChief Scientific OfficerS - Sale+OE$30.00-46,03495,100-33%-$1,381,020
D
2022-07-13
KROSLachey JenniferChief Scientific OfficerS - Sale+OE$30.00-1,91695,100-2%-$57,480
D
2022-05-11
KROSLachey JenniferChief Scientific OfficerS - Sale+OE$41.90-5,30085,700-6%-$222,050
D
2022-04-11
KROSLachey JenniferChief Scientific OfficerS - Sale+OE$62.77-5,30085,700-6%-$332,705
D
2022-04-06
KROSRovaldi ChristopherCOOS - Sale+OE$65.00-1,7280-100%-$112,320
D
2022-04-04
KROSLachey JenniferChief Scientific OfficerS - Sale+OE$60.00-7,95085,700-8%-$477,000
D
2022-04-01
KROSRovaldi ChristopherCOOS - Sale+OE$57.49-8640-100%-$49,675

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top